Conformis up 6% on FDA nod for new hip replacement system

Conformis (CFMS +6.1%) announces FDA clearance of its next-generation 3D-designed Conformis Hip System that, it says, incorporates improvements based on surgeon feedback after 400+ surgeries that began in July 2018.

Full commercial launch is underway.

https://seekingalpha.com/news/3517221-conformis-6-percent-fda-nod-new-hip-replacement-system